Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Dermatologic 1

Conditions

Meningeal Neoplasms 1 Melanoma 1 Lung Neoplasms 1

Interventions

Nivolumab 6 pembrolizumab 3 Ipilimumab 3 relatlimab 2 cemiplimab 2 Specimen Handling 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 vedolizumab 1 trametinib 1 toripalimab 1 sulforaphane 1 gadopiclenol 1 famitinib 1 anlotinib 1 X-Rays 1 Watchful Waiting 1 Toll-Like Receptor 1 1 Therapeutics 1 Temozolomide 1 Technetium 1 Standard of Care 1 Sentinel Lymph Node Biopsy 1 SHR-1701 1 Rehabilitation 1 Photopheresis 1 Pemetrexed 1 Paclitaxel 1 Observation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Melanoma × gadopiclenol × Clear all

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡